Form 4 for PFE Pfizer
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001225208-22-003473 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-25 | 2022-02-23 | PFE | Dolsten Mikael | Pres R, D | F - Tax | $46.87 | -29.8K | 323.9K | -8% | -$1.40M |
| DM | 2022-02-25 | 2022-02-24 | PFE | Dolsten Mikael | Pres R, D | A - Grant | $0.00 | +238.3K | 126.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | F | D | 29,767 | $46.87 | 323,862 | D | — | — | (F1) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon). |
| 2 | Derivative | Stock Appreciation Rights | 2022-02-24 | A | A | 111,516 | $0.00 | 111,516 | D | $45.96 · 2029-02-24 to 2029-02-24 | 111,516 Common Stock | (F3) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |
| 3 | Derivative | Stock Appreciation Rights | 2022-02-24 | A | A | 126,794 | $0.00 | 126,794 | D | $45.96 · 2027-02-24 to 2027-02-24 | 126,794 Common Stock | (F2) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |